Roberto MALLONE

City:

Paris

Country:

France

Published Applications:

Last publication date:

2025-03-13

Top Assignees for applications by Roberto MALLONE

The entities that hold a legal rights for patent applications filed by inventor MALLONE Roberto:

INSERM INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) 4 Paris, France
UNIVERSITE PARIS DESCARTES 3 Paris, France
UNIVERSITE DE PARIS 2 Paris, France
Centre National de la Recherche Scientifique (CNRS 2 Paris, France
ECOLE SUPERIEURE DE PHYSIQUE ET DE CHIMIE INDUSTRIELLES DE LA VILLE DE PARIS 2 Paris, France
Universite Paris Diderot-Paris 7 1 Paris, France
UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6) 1 Paris, France
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE 1 PARIS, France
UNIVERSITE LIBRE DE BRUXELLES 1 Brussels, Belgium
INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) 1 Paris, France

Recent patent applications by MALLONE Roberto

Roberto MALLONE from Paris, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-03-13

US20250084143A1

Chemistry; metallurgy

ANTIGENIC PEPTIDES DERIVING FROM UROCORTIN 3 AND USES THEREOF FOR THE DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES

#2 | 2021-03-11

US20210070819A1

Chemistry; metallurgy

ANTIGENIC PEPTIDES DERIVING FROM SECRETOGRANIN V AND USES THEREOF FOR THE DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES

#3 | 2021-01-28

US20210024603A1

Chemistry; metallurgy

Antigenic peptides deriving from urocortin 3 and uses thereof for the diagnosis and treatment of type 1 diabetes

#4 | 2021-01-28

US20210023209A1

Human necessities

ANTIGENIC PEPTIDES DERIVING FROM PCSK2 AND USES THEREOF FOR THE DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES

#5 | 2018-08-30

US20180244746A1

Chemistry; metallurgy

T cell receptors (TCR) and uses thereof for the diagnosis and treatment of diabetes

#6 | 2018-07-26

US20180207250A1

Human necessities

Methods and pharmaceutical compositions for inducing immune tolerance by mucosal vaccination with Fc-coupled antigens

#7 | 2017-03-16

US20170072032A1

Human necessities

PRENATAL THERAPY TO INDUCE IMMUNE TOLERANCE

#8 | 2016-11-24

US20160341718A1

Physics

METHODS FOR TESTING T CELL PRIMING EFFICACY IN A SUBJECT

#9 | 2016-03-10

US20160068808A1

Chemistry; metallurgy

Methods for stimulating antigen-specific T cell responses

#10 | 2014-09-18

US20140271701A1

Chemistry; metallurgy

USE OF MYCOBACTERIUM AVIUM PARATUBERCULOSIS PEPTIDES TO DIAGNOSE TYPE 1 DIABETES

InventorID:

1467445 ⎘